Historical record - last NADAC effective date: 9/22/2021
Product Information
NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by Pharmaceutical Associates, Inc., priced at $0.1264 per ML under NDC 00121081002. Its NADAC has been published 261 times since Oct 5, 2016.
FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.
Strength
100000 [USP'U]/mL
Manufacturer
Pharmaceutical Associates, Inc.NDC
00121081002
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/22/2021
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA203621FDA Approved
1/7/2016
TE Code
AA
On Market Since
2/1/2016
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 261 times since Oct 5, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1264 per ML |
|---|---|
| All-time high | $0.1628 (May 13, 2020) |
| All-time low | $0.1114 (Apr 17, 2019) |
| Median price | $0.1310 |
| Average price | $0.1329 |
| Largest weekly change | +20.7% (Aug 19, 2020) |
| Weeks tracked | 261 |
| Tracking since | Oct 5, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+7.0%
All
-0.8%
Last surveyed Sep 29, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by Pharmaceutical Associates, Inc., is $0.1264 per ML (NDC 00121081002), effective Sep 29, 2021.
How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has held within roughly two percent of its current level. It has been tracked across 261 weekly CMS publications since Oct 5, 2016.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?
Since Oct 5, 2016, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.1114 (Apr 17, 2019) to a high of $0.1628 (May 13, 2020), with a median of $0.1310 per ML.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0561 per ML — about 56% below NYSTATIN 100,000 UNIT/ML SUSP.
Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?
NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121081002) is labeled by Pharmaceutical Associates, Inc., and CMS classifies it as a generic product.